As of 2025, Advanced Instruments and Nova Biomedical are operating under a unified brand, driving innovation in the biopharmaceutical and clinical markets.
The strategic merger combines the strengths of both companies in analytical instrumentation, R&D, and global customer support, positioning them to support customer workflows and improve patient care worldwide.
"Our shared values—innovation, customer focus, and dedication to quality—are the foundation of this merger," said Byron Selman, President & CEO of Nova Biomedical.
Autor's resume: Merger unifies two industry leaders.